A8X-28141-16384
2 vaccinations
2 coded responses
22 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 674 / KS
- Registered
- 2021-02-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Registered in v-safe
-
2021-02-05
Dose 1 — Pfizer-BioNTech
-
2021-02-05
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Chills, Fatigue or tirednessAdult check-in
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-14
-
2021-02-19
Survey response — day 14, dose 1MedDRA: Oropharyngeal pain — Feeling: FairFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-26
-
2021-03-05
Dose 2 — Moderna
- 2021-03-05
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-08
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea, Epistaxis — Feeling: Good · Site: Pain, Redness, Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Nosebleeds, short of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2021-03-10
- 2021-03-12
- 2021-03-19
- 2021-03-28
- 2021-04-02
- 2021-04-09
- 2021-04-19
- 2021-06-06
- 2021-09-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Pfizer-BioNTech | |
| 2 | 2021-03-05 | Moderna |
Free text
Release 4 — day 14, dose 1
Symptoms: Sore throat
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Nosebleeds, short of breath
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Epistaxis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release